Skip to main content

and
  1. No Access

    Article

    Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype

    Non-invasive biomarkers are needed for metabolic dysfunction-associated fatty liver disease (MAFLD), especially for patients at risk of disease progression in high-prevalence areas. The microbiota and its meta...

    Flavia Noelia Mazzini, Frank Cook, John Gounarides, Sebastián Marciano in Metabolomics (2021)